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Neuronal circuits of fear memory and fear extinction
In daily conversation we rarely distinguish between "anxiety" and "fear". In our article, anxiety is referred to as a vague feeling of oppression and threat, whereas fear is related to a certain object (cue) or situation (context). For scientific assessment of these behavioral characteristics, indicators and parameters are required that allow systematic and quantitative analyses, besides the consideration of individually expressed and often subjectively experienced emotional states. One advantage in the domain of fear is that the confrontation with a real or potential threat triggers distinctive fear or alarm reactions, whereby autonomic responses (such as increases in blood pressure, heart rate and respiration rate), behavioral reactions (with undirected components, such as freezing, startle responses or eyelid reflexes and directed components, such as fight, flight or avoidance reactions) and hormonal responses (the release of stress hormones such as adrenalin and cortisol/corticosterone) can be distinguished and quantified. These alarm responses are highly conserved in phylogenetic terms, in that they occur in all mammals including humans. As pointed out by the Austrian linguist Wandruszka [31] , it becomes evident from our linguistic heritage that fear and anxiety have a large impact on human behavior. For instance, common German phrases are, "schreckhaft aufgerissene oder zusammengepresste Augen","ein wild schlagendes, sich zusammenkrampfendes Herz","stockender Atem","erstarrendes Bl ut","Leichenblässe","Angstschweiss und Zähneklappern","die ausgetrocknete, zusammengeschnürte Kehle","das sich sträubende Haar","der heisere Schrei des Entsetzens" und"die zitternde Lähmung des ganzen Körpers". English terms and expressions refer to "eyes wide with fear", "breath caught in fear", "chest tight with fear", "cold sweat", "as pale as a ghost". Another example is the fear-evoked paralysis that let Lot's wife freeze to a pillar of salt and the Edomites, Moabites and Canaanites turn to pillars of stone. "Catching someone red-handed" or"with their pants down", "having stage fright", "giving me the creeps" or "being headless" are further additions to the broad spectrum of fear-and anxiety-related expressions.
Fear responses are reflexive in that they are mediated through phylogenetically and ontogenetically defined reaction pathways. However, this does not mean that they occur exclusively in an automatic manner and that we are guided by emotional strands like puppets on a string. On the contrary, a plethora of neuronal networks determine the intensity of fear responses and permit adaptive dynamic changes. They allow us to avoid a potential threat by responding to appropriate anticipatory cues. Alternatively, they can suppress fear reactions once the threat turns out to be irrelevant. Individual variations in anxiety and fear result from complex interactions between genetic predisposition and autobiographical specificities (e.g. early childhood trauma). Extreme variation in, or perturbation of these mechanisms can lead to disproportional and prolonged (even irreversible) emotional states, which are experi-enced as excessive, persistent and/or omnipresent generalized fear and anxiety. This is the case in anxiety disorders which require therapeutic interventions.
Experimental animal models make an important contribution to the understanding of the physiological and genetic basis of fear and anxiety. These models allow us to assess the role of individual genes under controlled environmental conditions, to investigate the influence of environmental factors within a defined genetic background and thus, to systematically analyze the interplay between these two factors. The best-studied model system is fear conditioning [17] . We will use this model to illustrate the neurobiological principles underlying acquisition, expression, modulation and extinction of fear memories. For the sake of brevity and clarity, we will focus on major principles. Readers interested in more details are referred to a number of excellent review articles on the molecular and synaptic mechanisms [6, 11, 22, 23, 25] , gene × environment interactions (Sachser and Lesch, this issue), neuropsychological aspects (Glotzbach-Schoon et al., this issue) and the pathogenesis of anxiety disorders (Domschke, this issue).
Fear conditioning and fear extinction
Fear conditioning is a learning and memory process that is based on classical (or Pavlovian) conditioning, i.e. a stimulusstimulus association. In a prototypic experimental setting, experimental subjects 47 e-Neuroforum 3 · 2013 | learn within a single session to associate a tone (cue) or a particular environment (context) with an aversive stimulus (typically a weak electrical shock; the unconditioned stimulus, US) (. Fig. 1a ). This reductionist and controlled approach offers a number of advantages for systematic analysis of the underlying neural and molecular mechanisms: firstly, stages of formation (acquisition), long-term stabiliza-tion (consolidation) and retrieval (recall) of the memory can be distinguished and analyzed (. Fig. 1b) ; secondly, the behavioral expression of fear is readily detectable and can be quantified with ease. Re-exposure to the tone or the learning environment (the conditioned stimulus, CS+) after conditioning evokes a series of fear responses, of which freezing (i.e., immobility except for breathing-related movements) is typically used as a measure of the fear memory (. Fig. 1 ). Furthermore, the absence of the anticipated aversive stimulus upon re-exposure to the conditioned stimulus leads to a decline in conditioned fear, a process known as fear extinction. This process can be triggered by repeated or prolonged exposure to the tone/learning environment, which is referred to as extinction training (. Fig. 1 ). is presented in a defined environment (context A = configural conditioned stimulus, cCS) and coterminates with a brief electrical shock to the foot (unconditioned stimulus, US). Subsequent re-exposure to the conditioning context or the tone evokes a typical fear reaction (e.g. freezing). During extinction training, the tone is repeatedly presented without aversive stimulus (context B), thereby inducing relearning. This process creates a new memory trace, which interferes and eventually suppresses the initial fear memory. The re-emergence of the fear response elicited by the tone is indicative of a lack of erasure of the fear memory. This relapse can occur spontaneously with time (spontaneous recovery), through application of another unconditioned stimulus (reinstatement) or through presentation of the tone in a novel environment (context C, renewal). b Plotting the level of freezing in a learning curve indicates the various components of memory formation (acquisition, consolidation, retrieval) during both fear conditioning and fear extinction The term "extinction" is somewhat misleading, because fear memories are seldom truly erased. Extinction training rather results in the formation of a new memory trace ("the tone no longer signals a threat or danger"), which suppresses expression of the initial fear memory ("the tone signals a threat or danger"). The persistence of the initial fear memory can be deduced from the reoccurrence of conditioned fear with time (spontaneous recovery), following presentation of an aversive stimulus (reinstatement) or upon exposure to the conditioned tone in a new environment (renewal; . Fig. 1 ). In addition to extinction, a number of additional processes may result in a decline of fear responses. One of them is forgetting, i.e. the weakening of the fear memory trace with increased time between learning and memory retrieval. However, while time heals many wounds, some may persist, and evolution has guaranteed long-term storage of aversive memories. This, in turn, may have negative consequences for mental health. In fact, a number of anxiety disorders (e.g. posttraumatic stress disorder, agoraphobia, specific phobias, panic disorder) are associated with sustained strong fear reactions. A better understanding of the neurobiological principles underlying the development and decline of fear reactions is thus also of critical importance from a clinical perspective.
Neuronal circuits underlying formation and expression of fear memory
The fear matrix is comprised of brain regions located predominantly in the hypothalamus or the mes-/metencephalon that directly mediate the expression of fear (such as changes in blood pressure, heart rate and motor activity). Additional regions are involved in the modulation and control of fear reactions. The latter will be considered in more detail in the present article. In view of space limitations, we will focus on the prefrontal cortex, the hippocampal formation and the amygdaloid complex. With the development and use of a wide array of sophisticated technologies (. Fig. 2 ), a detailed knowledge of the neural basis of fear memory and fear extinction has been acquired during the last decade. Imaging techniques, electrophysiological studies and clinical examination of patients with localized brain lesions have revealed a high degree of homology between the neuronal matrix of fear regulation in humans and rodents (. Fig. 3 ).
The amygdala is comprised of more than a dozen nuclei, of which the central nucleus (central amygdala, CeA) and the basolateral amygdaloid complex are of particular importance for fear conditioning. The basolateral complex consists of three nuclei: the lateral (LA), the basolateral (BL) and the basomedial (BM) nucleus. Since many studies do not distinguish between these sites, we only refer to the LA and the basal part of the basolateral complex (BLA) in this article. The CeA was uncharted territory for a long time. Only recently have state-ofthe-art mouse genetics methods combined with electrophysiological and optogenetic tools (. Fig. 5 ) led to the identification of neuronal subpopulations in the CeA and their causal involvement in defined components of conditioned fear responses. These findings have substantially changed the previously held view of the CeA as a simple output station of the amygdala. Rather than being a homogeneous structure, the CeA-in an oversimplified scheme-is subdivided into a lateral (CeL) and a medial part (CeM), which convey specific components to fear reactivity: while projections from the CeM to the central gray matter (periaqueductal gray, PAG) mediate passive components of the fear response (such as freezing), projections from the CeL activate the neocortex via the basal forebrain, thereby enhancing arousal-provoking active fear responses (. Fig. 4b , [7] ).
During auditory fear conditioning (see . Fig. 1 ), sensory information concerning the acoustic stimulus and the aversive stimulus converge at the level of the LA. Upon coincidence of the two stimuli, signal transmission is potentiated at the appropriate synapses of LA neurons (elementary conditioning). With the help of memory-relevant transcription factors, subpopulations of LA neurons could be identified that are causally involved in expression of the fear memory [9] . Whether or not additional brain regions or pop-ulations of neurons contribute to the formation of fear memory is still a matter of debate. For instance, more complex information about the learning environment, which may contain temporally and spatially discontinuous elements of various modalities (e.g. odor, texture, material) is integrated in the hippocampal formation and relayed to the BLA (. Fig. 4b ), where it is linked with the aversive signal (contextual or configural conditioning; see . Fig. 1) .
For a long time, conditioned fear was seen as the result of serial processes, which included learning-dependent potentiation of signal transmission (synaptic plasticity) within the LA, followed by activation of the CeA and downstream effector sites
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(. Fig. 4a ). More recent findings demonstrate the existence of multiple parallel processes (. Fig. 4b ). Sensory signals reach the CeL and the CeM via excitatory neurons of the LA and BLA ("fear" neurons; . Fig. 4b, [10] ). The latter neurons are activated by projections from the prelimbic region of the prefrontal cortex (PrL) and their activity can be modified by influences from the hippocampal formation (. Fig. 4b ). In addition, specialized subpopulations of CeL neurons exist that signal the onset and the termination of the fear-conditioned stimulus (ON, OFF neurons) and which are directly involved in learning-dependent process-es of synaptic plasticity [2] . Furthermore, the CeL is innervated by axonal projections from the hypothalamus, which release the neuropeptides vasopressin and oxytocin that can affect both hormonal and emotional components of the fear response [30] . Other neuropeptides, such as neuropeptide S (NPS) or Y (NPY), mod- ulate the fear response at the level of LA/ BLA (see below). Despite this detailed knowledge of synaptic interconnections in the amygdala, it is still unclear how specialized and spatially distributed neuronal populations are selected and functionally linked in the formation of fear memory. One possible mechanism is the functional coupling of neuronal subpopulations by the temporal synchronization of their activity. Simul-taneous electrophysiological recordings in the amygdala, hippocampus and prefrontal cortex of the mouse revealed synchronization of neuronal population activity in the θ frequency range (4-10 Hz) during consolidation and retrieval of fear memory [18, 28] . This synchronized activity is considered to functionally couple neuronal subpopulations across brain areas. Fear memory and fear extinction are characterized by regionally specific pat-terns of θ synchronization that can be simulated by targeted deep brain stimulation [18] . Moreover, θ activity is prominent during certain sleep stages (e.g., rapid eye movement, REM sleep), where it seems to promote the consolidation of fear memories [20, 26] .
Neuronal circuits of fear extinction
In order to understand the mechanisms underlying the active suppression of fear memories (see . Fig. 1) , we have to extend our picture of the amygdala complex by considering additional brain structures. Of utmost importance is the fact that the infralimbic region of the prefrontal cortex (IL; . Fig. 6 ) takes over a central part of inhibiting the fear response [21, 22] . It became evident that the IL does not directly influence the LA (. Fig. 6 ), but rather recruits highly specialized GA-BAergic interneurons in the amygdala that are termed intercalated cells (ICT or ICM). These ICT/ICM neurons are organized in neuronal clusters at the interface between the LA/BLA and the CeA (. Fig. 6b , [14, 19] ) and are innervated by LA/BLA neurons. Increased firing of these neuronal clusters results in a reduction of CeL/CeM activity and consequently, in a decrease in the fear response (. Fig. 6b ). Furthermore, in addition to the above mentioned fear neurons, which are involved in encoding of the fear memory (. Fig. 4b ), so-called "extinction neurons" exist in the BLA. These extinction neurons respond with increased spike firing upon presentation of the conditioned signal (tone) after successful extinction training ("no fear "neurons) [10] . These neurons likely play a role in mediating the decrease of the fear response during extinction (. Fig. 6b ), either by controlling the CeM output via the CeL or by activating extinction-relevant neurons in the IL.
It is important to note that extinction memory is strongly linked to the extinction context. This is achieved through involvement of the ventral hippocampus (vHPC) and its projections into the PrL, where the activation of fear-enhancing projection neurons is suppressed (mediated via inhibitory interneurons, . Fig. 6b,  [29] ). 
Potential significance of animal studies for the understanding and treatment of anxiety disorders
The newly uncovered neuroanatomical basis and neurochemical processes underlying acquisition and extinction of fear memories may pave the way for the development of novel diagnostic or therapeutic strategies for anxiety disorders. A hallmark of anxiety disorders is the disproportional, prolonged and often omnipresent state of fear, which is experienced as excessive anxiety. Examples are specific phobias, agoraphobia, panic disorders and posttraumatic stress disorder (see Domschke, this issue). Clinical symptoms are often intensified by processes of classical and/or operant conditioning, which together result in aberrant avoidance behavior. The treatment of anxiety disorders includes cognitive behavioral therapies. One prominent example is exposure therapy, during which the patient is confronted with fear-triggering stimuli and memories. This controlled and repeated exposure is intended to result in new learning and reappraisal, thereby largely resembling the fear conditioning/extinction paradigms described above. A legitimate question is therefore whether or not we can specify any novel therapeutic approach that has been derived from animal research, and if so, what are its clinical implications? A substantial improvement in the treatment of anxiety disorders might be achieved by specific pharmacological approaches that supplement exposure therapy. More specifically, a beneficial therapeutic effect will be obtained if the magnitude of the acute stress state during exposure is attenuated ("happy pills") and/or if the efficacy of the new learning during training (i.e. the extinction) is amplified ("smart pills"). The use of classical anxiolytic drugs such as benzodiazepines cannot be recommended, because these substances impair new learning and reappraisal. As a far preferable alternative, a pharmacologically active substance might be used that induces a more selective depression of excitatory fear neurons or fear pathways, or which boosts the activity of inhibitory influences (no-fear neurons). A number of promising substances that ful-fill these requirements have emerged from animal experiments (. Fig. 7) .
Firstly, endocannabinoids (ECB) act as retrograde transmitters that constrain synaptic transmission in both BLA and CeA [27] . Secondly, NPS is increasingly released into the amygdala upon stressful encounters, where it facilitates synaptic activation of the GABAergic neurons in the ITC/ICM [14] . Thirdly, oxytocin (OXT) may activate specific GAB-Aergic subpopulations in the CeL, thus resulting in a dampening of output signals to the hypothalamus and brain stem [30] . A common consequence of each of these interventions is the decline of acute fear reactions along a faster time course (happy pills, . Fig. 7a) , with processes of relearning being unaffected or even facilitated. Furthermore, experimental animal studies have led to the identification of Dcycloserine, a positive allosteric modulator/partial agonist of the NMDA receptor that directly potentiates extinction training (smart pills, . Fig. 7b ). Within less than 2 years of its initial discovery, D-cycloserine was successfully tested in clinical trials, where it improved exposure therapy of acrophobia [3] . One general and severe problem of exposure therapies is the relatively high relapse rate. This might be explained by the fact that exposure therapies induce new learning without erasure of the initial fear memory, thereby resembling extinction training in experimental studies. As explained previously, fear extinction is strongly linked to the context in which extinction training took place (. Fig. 1 ). When this particular contextual memory has begun to fade away or the fearful encounter occurs in a different context, fear responses are likely to reoccur (spontaneous recovery, renewal; . Fig. 1) . In addition, severe stress or pain can induce a potentiation of the fear reaction (reinstatement; . Fig. 1 ). These conditions of high or potentiated fear (sustained fear) involve neuronal pathways of the PrL and the bed nucleus of the stria terminals (BNST;
. Fig. 6c, [4, 13, 15, 29] ).
True erasure of the initial fear memory would thus have a number of advantages, including a reduced risk of relapse. Only 10 years ago, such a scenario would have been considered impossible. The scientific understanding at that time was that longterm memories are inert to internal or external influences once they are consolidated. Nowadays we know that recall of fear memories may convert the activated fear matrix back into a vulnerable state. This state recapitulates part of the biochemical processes underlying fear conditioning and is termed reconsolidation [24] . If reconsolidation is impaired by pharmacological means, fear reactions will be reduced with no risk of subsequent renewal, reinstatement or spontaneous recovery. This might be achieved, for example, by application of a betablocker (β-adrenergic receptor antagonist) in both animals [5] and humans [16] . It is fair to add that the latter studies were performed in healthy subjects and that validation in anxiety patients still lacking. While these findings are very promising, the possibility of memory erasure raises ethical concerns. Upon introspection, everyone can recognize that fear memories are comprised of various components, including explicit (or narrative) and implicit elements. For instance, we appreciate that an oven may be hot and we have learned (some by painful experience) to pay attention to this possibility. However, this does not mean that we start to cry or shake with fear whenever we remember our individual experience. In other words, explicit memory compo-nents are primarily adaptive, whereas implicit components (which directly mediate the fear responses) may become maladaptive. Therefore, one important goal of future studies should be to selectively target reconsolidation of implicit memory components, while leaving the explicit components unaffected (. Fig. 7c ). Studies tackling reconsolidation in humans seem to have met this goal: the specific intervention protocol resulted in an interruption of the subconscious (implicit) components of fear reactions, with no concomitant interference with the subjects' ability to explicitly identify the fear-associated stimulus [16] . From an anatomical point of view, the amygdala and the hippocampal formation are likely candidates for encoding of implicit and explicit memory components, respectively [1] . A more detailed knowledge about the regionally specific mechanisms mediating the various components of fear responses, including active and passive, implicit and explicit aspects, is key to the future development of specific and individualized intervention strategies.
Another intervention strategy aimed at preventing the negative consequences of stress and pain on the relapse of fear (reinstatement) might interfere with neuropetidergic (e.g. NPS, CRH or NPY) or monoaminergic systems (. Fig. 7d , [4, 8, 32] ).
Conclusion

Nowadays, we have a good understanding of the anatomical and physiological basis underlying the acquisition and extinction of fear in rodents. This detailed knowledge provides a feasible basis for specific interventions that successfully increase the efficacy of fear extinction
and thereby reduce the risk of relapse of fear symptoms. However, the vast majority of findings have been obtained from studies employing auditory fear conditioning, which is an established and accepted model of specific phobias. In the future, it will be crucial to extend the analysis to animal models of anxiety disorders that possess more complex symptoms and that are more difficult to treat, such as agoraphobia or generalized anx- 1), which, via the activation of a specialized cluster of intercalated GABAergic interneurons (ITC) inhibits the medial section of the CeA (CeM) and thereby suppress the fear response (2) . An important influence is conveyed by the extinction context, which mediates an additional safety signal. This signal is transmitted via the ventral hippocampus (vHPC) to the prelimbic region of the prefrontal cortex (PrL), where inhibitory interneurons are activated to suppress activity of the fear-promoting projection neurons (3) . c A number of incidences provoke a relapse of fear after its extinction (compare Fig. 1 ). For instance, renewal of the fear response can occur upon presentation of the tone in a novel environment that differs from the extinction context. Prolongation of the fear reaction (sustained fear), as induced by excessive stress or pain for instance (reinstatement), critically recruits projections to and from the bed nucleus of the stria terminalis (BNST). Note that the circuit diagram has been highly simplified, illustrating only major projections. Inhibitory neurons are shown in blue and excitatory neurons in red. CeL lateral section of the CeA, vHPC ventral hippocampus iety disorders. Furthermore, pharmacological intervention strategies should aim to uncouple the explicit components of the fear response (which have to be preserved for identification of any potential threat) and the implicit, automatized elements. It is fair to say that experimental animal models are certainly not capable of mimicking the complexity of an anxiety disorder in every detail. However, transfer of conclusions reached in experimental animal studies to the situation in humans is both feasible and justified by the remarkable homology of the physiological, neurochemical, and-last but not least-anatomical constituents of fear memory and fear extinction in rodents and humans. Fig. 1; 6c) . One possibility to prevent relapse is interference with memory reconsolidation. This might be achieved through application of a betablocker (β adrenergic receptor antagonists such as propranolol). Importantly, this treatment does not interfere with the explicit components of the fear memory ("oven might be hot"), but induces disintegration of the association with automatically occurring (implicit) components of the fear reactions. d States of high fear resulting, e.g., from encounters with excessive stress or repeated traumatic experience (compare Fig. 1; 6c ), can be improved or even prevented by chronic application of selective serotonin reuptake inhibitors (SSRI) or acute application of antagonists to corticotropin-releasing hormone receptors (CRHR1 antagonist). It should be noted that the various scenarios of pharmacological intervention have been exemplified with selected neurons and networks, only partly representing the overall fear matrix, which involves additional brain regions
